{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:41:15Z","timestamp":1790700075377,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["\/NICHD 1U54HD071594-05"],"award-info":[{"award-number":["\/NICHD 1U54HD071594-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pcl.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T17:18:29Z","timestamp":1511457509000},"page":"1327-1340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Non-steroidal Anti-inflammatory Drugs in Newborns and Infants"],"prefix":"10.1016","volume":"64","author":[{"given":"Jacob V.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria B.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay D.","family":"Beharry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2017.08.009_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpeds.2017.03.021","article-title":"Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes","volume":"187","author":"Liebowitz","year":"2017","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.clp.2011.12.002","article-title":"Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit","volume":"39","author":"Johnston","year":"2012","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.pcl.2017.08.009_bib3","series-title":"Goodman and Gilman- The pharmacologic basis of therapeutics","article-title":"Anti-inflammatory, antipyretic and analgesic agents: pharmacotherapy of gout","author":"Grosser","year":"2011"},{"key":"10.1016\/j.pcl.2017.08.009_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0028-1103515","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants","volume":"26","author":"Aranda","year":"2009","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.pcl.2017.08.009_bib5","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J\u00a0Pharm Pharm Sci"},{"issue":"6","key":"10.1016\/j.pcl.2017.08.009_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2017.08.009_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1089\/ars.2010.3474","article-title":"Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke","volume":"14","author":"Rink","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pcl.2017.08.009_bib8","first-page":"767","article-title":"Selective inhibition of cyclooxygenase-2: risks and benefits","volume":"52","author":"Mendes","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"Suppl","key":"10.1016\/j.pcl.2017.08.009_bib9","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.pcl.2017.08.009_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1570159X13666151102103305","article-title":"Eicosanoids derived from arachidonic acid and their family prostaglandins and cyclooxygenase in psychiatric disorders","volume":"13","author":"Yui","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib11","first-page":"91","article-title":"Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors","volume":"4","author":"Harris","year":"2012","journal-title":"J\u00a0Exp Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase-2 deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pcl.2017.08.009_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI5505","article-title":"Angiotensin II attenuates renal cortical cyclooxygenase-2 expression","volume":"103","author":"Cheng","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pcl.2017.08.009_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903550208","article-title":"Characterization of inducible cyclooxygenase in rat brain","volume":"355","author":"Breder","year":"1995","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.pcl.2017.08.009_bib15","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic=antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pcl.2017.08.009_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.pcl.2017.08.009_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pcl.2017.08.009_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pcl.2017.08.009_bib19","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M003504200","article-title":"Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis","volume":"275","author":"Tanioka","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pcl.2017.08.009_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pcl.2017.08.009_bib21","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1073\/pnas.1332766100","article-title":"Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase","volume":"100","author":"Trebino","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pcl.2017.08.009_bib22","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","article-title":"Prostaglandin E receptors","volume":"282","author":"Sugimoto","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pcl.2017.08.009_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1253\/circj.CJ-10-0195","article-title":"Prostacyclin in vascular diseases","volume":"74","author":"Kawabe","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.pcl.2017.08.009_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2005.08.021","article-title":"Cellular and molecular biology of prostacyclin synthase","volume":"338","author":"Wu","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pcl.2017.08.009_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1471-4159.2006.04339.x","article-title":"Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia","volume":"101","author":"Noda","year":"2007","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.pcl.2017.08.009_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1476-5381.2008.00060.x","article-title":"Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors","volume":"156","author":"F\u00e9l\u00e9tou","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"The thromboxane\/endoperoxide receptor (TP): the common villain. Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.imlet.2005.10.004","article-title":"Positioning prostanoids of the D and J series in the immunopathogenic scheme","volume":"102","author":"Herlong","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.pcl.2017.08.009_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.RES.0000170888.11669.28","article-title":"COX-2-derived prostacyclin modulates vascular remodeling","volume":"96","author":"Rudic","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pcl.2017.08.009_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.CIR.59.1.169","article-title":"Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities","volume":"59","author":"Heymann","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.pcl.2017.08.009_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.chembiol.2017.02.003","article-title":"Non-steroidal anti-inflammatory drugs are caspase inhibitors","volume":"24","author":"Smith","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.pcl.2017.08.009_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1996.03530310045031","article-title":"Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants","volume":"275","author":"Varvarigou","year":"1996","journal-title":"JAMA"},{"issue":"9449","key":"10.1016\/j.pcl.2017.08.009_bib33","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(04)17477-1","article-title":"Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"364","author":"Van Overmeire","year":"2004","journal-title":"Lancet"},{"issue":"9449","key":"10.1016\/j.pcl.2017.08.009_bib34","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/S0140-6736(04)17476-X","article-title":"Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial","volume":"364","author":"Gournay","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcl.2017.08.009_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.semperi.2006.04.003","article-title":"Systematic review: intravenous ibuprofen in preterm newborns","volume":"30","author":"Aranda","year":"2006","journal-title":"Semin Perinatol"},{"issue":"2","key":"10.1016\/j.pcl.2017.08.009_bib36","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","author":"Ohlsson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2017.08.009_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1651-2227.1997.tb08892.x","article-title":"Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant","volume":"86","author":"Aranda","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib38","series-title":"Ibuprofen a critical bibliographic review","first-page":"87","article-title":"The pharmacokinetics of ibuprofen in humans and animals","author":"Brocks","year":"1999"},{"issue":"8","key":"10.1016\/j.pcl.2017.08.009_bib39","doi-asserted-by":"crossref","first-page":"e12329","DOI":"10.1371\/journal.pone.0012329","article-title":"Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?","volume":"5","author":"Durrmeyer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2017.08.009_bib40","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0091270008323752","article-title":"Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants","volume":"48","author":"Gregoire","year":"2008","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib41","doi-asserted-by":"crossref","first-page":"F116","DOI":"10.1136\/adc.2011.215160","article-title":"Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants","volume":"97","author":"Barzilay","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pcl.2017.08.009_bib42","first-page":"1","article-title":"Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants","volume":"25","author":"Demir","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.pcl.2017.08.009_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2710.2005.00630.x","article-title":"Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method","volume":"30","author":"Desfrere","year":"2005","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pcl.2017.08.009_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-1033.1988.tb13792.x","article-title":"Higher oxidation states of prostaglandin H synthase EPR study of a transient tyrosyl radical in the enzyme during the peroxidase reaction","volume":"171","author":"Karthein","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pcl.2017.08.009_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clpt.2005.09.009","article-title":"New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases","volume":"79","author":"Aronoff","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1542\/peds.93.4.641","article-title":"Acetaminophen analgesia in neonatal circumcision: the effect on pain","volume":"93","author":"Howard","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2017.08.009_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(00)00336-5","article-title":"Effects of rectally administered paracetamol on infants delivered by vacuum extraction","volume":"94","author":"van Lingen","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"10.1016\/j.pcl.2017.08.009_bib49","article-title":"Paracetamol (acetaminophen) for prevention or treatment of pain in newborns","author":"Ohlsson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2017.08.009_bib50","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","article-title":"Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment","volume":"128","author":"Hammerman","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2017.08.009_bib51","doi-asserted-by":"crossref","first-page":"F127","DOI":"10.1136\/archdischild-2014-307312","article-title":"Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis","volume":"101","author":"Terrin","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pcl.2017.08.009_bib52","doi-asserted-by":"crossref","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pcl.2017.08.009_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib54","unstructured":"Acetaminophen pathway. Available at: https:\/\/www.pharmgkb.org\/pathway\/PA165986279. Accessed April 15, 2017."},{"key":"10.1016\/j.pcl.2017.08.009_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00228-015-1887-y","article-title":"Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants","volume":"71","author":"Krekels","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/adc.2010.192005","article-title":"Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines","volume":"96","author":"Beringer","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pcl.2017.08.009_bib57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.jp.7211641","article-title":"Acetaminophen-induced hepatic failure with encephalopathy in a newborn","volume":"27","author":"Walls","year":"2007","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.pcl.2017.08.009_bib58","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1136\/fn.89.1.F25","article-title":"Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age","volume":"89","author":"Allegaert","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pcl.2017.08.009_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bja\/aen208","article-title":"I.V. acetaminophen pharmacokinetics in neonates after multiple doses","volume":"101","author":"Palmer","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pcl.2017.08.009_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40262-015-0301-3","article-title":"Population pharmacokinetics of intravenous paracetamol (acetaminophen) in preterm and term neonates: model development and external evaluation","volume":"55","author":"Cook","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.pcl.2017.08.009_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/bja\/aet559","article-title":"Intravenous paracetamol dosage in the neonate and small infant","volume":"112","author":"Veyckemans","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pcl.2017.08.009_bib62","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1136\/fn.80.1.F59","article-title":"Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates","volume":"80","author":"van Lingen","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pcl.2017.08.009_bib63","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1034\/j.1399-6576.1999.430813.x","article-title":"Plasma paracetamol concentrations and pharmacokinetics following rectal administration in neonates and young infants","volume":"43","author":"Hansen","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.pcl.2017.08.009_bib64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1460-9592.1997.d01-126.x","article-title":"Plasma concentrations after rectal administration of acetaminophen in preterm neonates","volume":"7","author":"Lin","year":"1997","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.pcl.2017.08.009_bib65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0009-9236(99)70014-7","article-title":"Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants","volume":"66","author":"van Lingen","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197609022951003","article-title":"Pharmacologic closure of patent ductus arteriosus in the premature infant","volume":"295","author":"Friedman","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2017.08.009_bib67","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-3476(83)80022-5","article-title":"Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study","volume":"102","author":"Gersony","year":"1983","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib68","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","article-title":"Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants","volume":"344","author":"Schmidt","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pcl.2017.08.009_bib69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1542\/peds.93.4.543","article-title":"Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial","volume":"93","author":"Ment","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2017.08.009_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-3476(85)80197-9","article-title":"Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants","volume":"107","author":"Ment","year":"1985","journal-title":"J\u00a0Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2017.08.009_bib71","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","author":"Fowlie","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2017.08.009_bib72","first-page":"251","article-title":"A\u00a0comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus","volume":"1","author":"Evans","year":"1981","journal-title":"Pediatr Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib73","first-page":"313","article-title":"Disposition of indomethacin in preterm infants","volume":"95","author":"Bhat","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3565(25)29239-4","article-title":"The metabolism of indomethacin in man","volume":"181","author":"Duggan","year":"1972","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000457493","article-title":"Metabolism and disposition of indomethacin in preterm infants","volume":"17","author":"Friedman","year":"1991","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/clpt.1991.65","article-title":"Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus","volume":"49","author":"Wiest","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib77","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3476(80)80446-X","article-title":"The disposition of indomethacin in preterm babies","volume":"97","author":"Yaffe","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000455528","article-title":"Pharmacokinetics of oral and intravenous indomethacin in preterm infants","volume":"1","author":"Bhat","year":"1980","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3476(80)80445-8","article-title":"Pharmacokinetics of intravenously administered indomethacin in premature infants","volume":"97","author":"Thalji","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib80","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1542\/peds.2005-0293","article-title":"Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33\u00a0weeks of gestation","volume":"116","author":"Sperandio","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.pcl.2017.08.009_bib81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2008.01.031","article-title":"Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial","volume":"153","author":"Jegatheesan","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib82","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.jvca.2004.05.024","article-title":"Prospective randomized trial of ketorolac after congenital heart surgery","volume":"18","author":"Gupta","year":"2004","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.pcl.2017.08.009_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S1047951109003527","article-title":"Safety of intravenous use of ketorolac in infants following cardiothoracic surgery","volume":"19","author":"Dawkins","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.pcl.2017.08.009_bib84","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jpedsurg.2011.03.031","article-title":"Safety of ketorolac in surgical neonates and infants 0 to 3\u00a0months old","volume":"46","author":"Aldrink","year":"2011","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.pcl.2017.08.009_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2431-4-15","article-title":"Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study","volume":"4","author":"Avila-Vazquez","year":"2004","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.pcl.2017.08.009_bib86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3928\/01913913-20100920-01","article-title":"Effectiveness of ketorolac tromethamine in prevention of severe retinopathy of prematurity","volume":"48","author":"Giannantonio","year":"2011","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.pcl.2017.08.009_bib87","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/pr.2016.105","article-title":"Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy","volume":"80","author":"Aranda","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pcl.2017.08.009_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MJT.0b013e31818071df","article-title":"Population pharmacokinetics of ketorolac in neonates and young infants","volume":"16","author":"Zuppa","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.pcl.2017.08.009_bib89","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2125.1991.tb05510.x","article-title":"The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children","volume":"31","author":"Olkkola","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib90","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/00003088-199223060-00003","article-title":"Clinical pharmacokinetics of ketorolac tromethamine","volume":"23","author":"Brocks","year":"1992","journal-title":"Clin Pharmacokinet"},{"issue":"6 Pt 2","key":"10.1016\/j.pcl.2017.08.009_bib91","first-page":"33S","article-title":"Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals","volume":"10","author":"Mroszczak","year":"1990","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pcl.2017.08.009_bib92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2125.1994.tb04243.x","article-title":"The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate","volume":"37","author":"Hayball","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pcl.2017.08.009_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.17305\/bjbms.2016.1515","article-title":"Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period","volume":"17","author":"Kulo","year":"2017","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.pcl.2017.08.009_bib94","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0009-9236(99)70131-1","article-title":"Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children","volume":"65","author":"Kauffman","year":"1999","journal-title":"Clin Pharmacol Ther"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395517301128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395517301128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T09:07:48Z","timestamp":1751015268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395517301128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0031395517301128"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2017.08.009","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-steroidal Anti-inflammatory Drugs in Newborns and Infants","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}